About Actin nucleation-promoting factor WASL
Actin nucleation-promoting factor WASL (WASL) is a protein
from Homo sapiens identified by UniProt accession
O00401, 505 residues long.
MolForge cross-references it against 0 known binders and
128 disease associations.
Target properties
| Protein name | Actin nucleation-promoting factor WASL |
| UniProt accession | O00401 |
| Gene | WASL |
| Organism | Homo sapiens |
| Length | 505 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (128)
Diseases linked to this target (Open Targets).
- platelet count · score 0.35
- neurodegenerative disease · score 0.33
- mean platelet volume · score 0.31
- mean corpuscular hemoglobin concentration · score 0.31
- reticulocyte count · score 0.29
- mean corpuscular volume · score 0.29
- platelet crit · score 0.27
- reticulocyte measurement · score 0.27
- HbA1c measurement · score 0.24
- calcium measurement · score 0.24
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O00401-F1 | alphafold | PREDICTED | 68.74 | — |
Amino-acid sequence (505 residues)
MSSVQQQPPP PRRVTNVGSL LLTPQENESL FTFLGKKCVT MSSAVVQLYA ADRNCMWSKK CSGVACLVKD NPQRSYFLRI FDIKDGKLLW EQELYNNFVY NSPRGYFHTF AGDTCQVALN FANEEEAKKF RKAVTDLLGR RQRKSEKRRD PPNGPNLPMA TVDIKNPEIT TNRFYGPQVN NISHTKEKKK GKAKKKRLTK ADIGTPSNFQ HIGHVGWDPN TGFDLNNLDP ELKNLFDMCG ISEAQLKDRE TSKVIYDFIE KTGGVEAVKN ELRRQAPPPP PPSRGGPPPP PPPPHNSGPP PPPARGRGAP PPPPSRAPTA APPPPPPSRP SVAVPPPPPN RMYPPPPPAL PSSAPSGPPP PPPSVLGVGP VAPPPPPPPP PPPGPPPPPG LPSDGDHQVP TTAGNKAALL DQIREGAQLK KVEQNSRPVS CSGRDALLDQ IRQGIQLKSV ADGQESTPPT PAPTSGIVGA LMEVMQKRSK AIHSSDEDED EDDEEDFEDD DEWED
Explore Actin nucleation-promoting factor WASL with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets